ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Maximizing Peri-Operative Value-Based Care in Kidney Transplant Induction

J. Fleming,1 J. Casale,1 K. Covert,1 K. Boyle,1 D. Taber,2 H. Meadows,1 C. Mardis,1 N. Pilch,1 M. Posadas-Salas,3 T. Srinivas,3 C. Bratton,2 J. McGillicuddy,2 K. Chavin,2 P. Baliga.2

1Pharmacy, MUSC, Charleston, SC
2Surgery, MUSC, Charleston, SC
3Nephrology, MUSC, Charleston, SC.

Meeting: 2015 American Transplant Congress

Abstract number: A221

Keywords: Antilymphocyte antibodies, Kidney transplantation, Resource utilization, Simulect

Session Information

Session Name: Poster Session A: Non Organ Specific, Economics, Public Policy, Allocation, Ethics

Session Type: Poster Session

Date: Saturday, May 2, 2015

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Due to the dwindling reimbursement for kidney transplants (KTx), there must be a continuous effort to provide the best value-based care. The purpose of this study was to compare the cost-efficiency of two induction therapy protocols that have demonstrated equivalent efficacy.

METHODS: A cost-minimization analysis was performed from the societal perspective comparing two distinct induction therapy protocols. The efficacy data was compiled from a single center retrospective cohort study of adult KTxs comparing two induction protocols between 8/2011-12/2013. A protocol revision in 2012 adjusted the targeted population for rabbit antithymocyte globulin (RATG) induction to high immunologic risk recipients (Table 1). Direct medication cost was taken from the wholesale acquisition cost (WAC) for the medications. We also performed a sensitivity analysis, in which cost savings was analyzed if the IL2RA were to cost 25% more and if the RATG were to cost 25% less. The results of this study were expressed in median cost per 100 patients treated according to each protocol.

RESULTS: Outcomes were equivalent between the two protocol groups (Table 2, Figure 1). Table 3 demonstrates the median WAC for each induction agent based on our patient population and protocol. RATG utilization decreased from 61% to 28%, while IL2RA increased from 39% to 72% (Table 3). The median WAC for induction agents per 100 pts decreased by 28% with the new protocol, saving approximately $294,281.13 to treat 100 patients. In our sensitivity analysis, the cost for induction agents per 100 pts in the new protocol remained 15% below the old protocol.

CONCLUSIONS: A data-driven protocol that reserves RATG for high-immunologic risk patients reduces medication costs by 28% while maintaining equivalent efficacy and safety. As the population of kidney transplant recipients is constantly changing, regular reanalysis and confirmation would be beneficial.

[figure2]

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Fleming J, Casale J, Covert K, Boyle K, Taber D, Meadows H, Mardis C, Pilch N, Posadas-Salas M, Srinivas T, Bratton C, McGillicuddy J, Chavin K, Baliga P. Maximizing Peri-Operative Value-Based Care in Kidney Transplant Induction [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/maximizing-peri-operative-value-based-care-in-kidney-transplant-induction/. Accessed May 21, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences